Zimmer Biomet Holdings Inc (ZBH)

Profitability ratios

Return on sales

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit margin 17.72% 18.38% 18.24% 18.02% 18.09% 12.87% 13.03% 12.96% 11.50% 9.73% 8.99% 8.73% 9.01% 30.67% 42.06% 50.54% 62.84% 64.08% 64.46% 66.02%
Operating profit margin 17.29% 16.97% 16.98% 16.86% 17.82% 12.69% 12.50% 11.90% 10.27% 12.57% 12.12% 10.97% 11.54% 14.75% 15.46% 11.52% 1.21% 0.12% -0.66% 4.36%
Pretax margin 13.92% 13.98% 13.99% 13.78% 14.87% 10.02% 9.51% 8.48% 5.07% 4.48% 4.28% 3.81% 6.11% 10.43% 11.44% 7.04% -3.43% -2.66% -3.68% 1.46%
Net profit margin 12.16% 14.69% 13.68% 13.36% 14.28% 6.72% 7.23% 6.49% 3.41% 4.07% 3.25% 2.99% 5.39% 10.62% 11.86% 8.20% -2.03% -2.21% 0.54% 4.96%

Zimmer Biomet Holdings Inc's profitability ratios have shown some fluctuations over the quarters analyzed.

1. Gross Profit Margin: The gross profit margin has shown a declining trend from around 66% in March 2020 to a low of 9.01% in December 2021, followed by an upward trend to 18.09% in December 2023 and maintained around 18% in the subsequent quarters.

2. Operating Profit Margin: The operating profit margin has been volatile, with negative margins in some quarters initially, but gradually improving to reach around 17-18% by December 2024.

3. Pretax Margin: The pretax margin has also shown variability but generally an increasing trend over the quarters, reaching around 13-14% by the end of 2024.

4. Net Profit Margin: The net profit margin has also demonstrated fluctuations, with negative margins in some periods, but it has generally improved over time, reaching around 12-14% by the end of 2024.

Overall, it appears that Zimmer Biomet Holdings Inc has managed to improve its profitability margins over the quarters analyzed, with a more stable and positive trend observed in the recent periods. Still, variability in the margins highlights the need for continuous monitoring and management of costs and operational efficiency to sustain and enhance profitability levels.


Return on investment

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating return on assets (Operating ROA) 6.02% 5.76% 5.75% 5.67% 5.94% 4.22% 4.10% 3.88% 3.31% 4.02% 3.99% 3.70% 3.67% 4.74% 4.93% 3.32% 0.34% 0.03% -0.19% 1.30%
Return on assets (ROA) 4.23% 4.99% 4.63% 4.49% 4.76% 2.24% 2.37% 2.12% 1.10% 1.30% 1.07% 1.01% 1.71% 3.41% 3.78% 2.36% -0.57% -0.63% 0.16% 1.48%
Return on total capital 7.22% 7.31% 7.41% 6.98% 7.36% 5.08% 4.98% 4.75% 4.05% 4.96% 4.95% 4.62% 4.75% 5.94% 6.16% 3.99% 0.42% 0.04% -0.23% 1.69%
Return on equity (ROE) 7.25% 8.76% 7.83% 7.65% 8.20% 3.79% 4.09% 3.70% 1.93% 2.27% 1.89% 1.81% 3.17% 6.45% 7.28% 4.56% -1.14% -1.28% 0.32% 3.17%

Zimmer Biomet Holdings Inc's profitability ratios show varying levels over the analyzed periods.

1. Operating Return on Assets (Operating ROA): This ratio indicates the company's operating efficiency in generating profits from its assets. Over the period, the Operating ROA has been fluctuating, with the highest value recorded at 6.02% in December 31, 2024.

2. Return on Assets (ROA): ROA measures the company's ability to generate profits from its total assets. The trend shows improvement in profitability, with the highest value of 4.99% recorded in September 30, 2024.

3. Return on Total Capital: This ratio evaluates the company's efficiency in generating returns for both debt and equity holders. The Return on Total Capital has been relatively stable, with a peak of 7.41% on June 30, 2024.

4. Return on Equity (ROE): ROE reflects the profitability from the shareholders’ perspective. The ratio shows a positive trend, reaching a high of 8.76% on September 30, 2024.

Overall, Zimmer Biomet Holdings Inc has shown improvements in profitability ratios over the analyzed periods, indicating efficient asset utilization and increased returns for both shareholders and capital providers.